SCHEMBL21167673

SCHEMBL21167673

CC(C)n1cc(-c2cnc(N)c(NCc3ccc4nccn4c3)n2)cn1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.45
MET P08581 8/20 0.42
KEAP1 Q14145 1/20 0.39
NQO2 P16083 1/20 0.38
NAMPT P43490 2/20 0.38
FGFR1 P11362 2/20 0.38
FGFR2 P21802 2/20 0.38
FGFR3 P22607 2/20 0.38
LDHA P00338 1/20 0.37
LDHB P07195 1/20 0.37
MAPK1 P28482 1/20 0.37
PAK1 Q13153 1/20 0.35
TRIM33 Q9UPN9 1/20 0.34
TYRO3 Q06418 1/20 0.34
DYRK1A Q13627 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22475807 0.90 MET (0.42) CSF1RMETKEAP1NQO2NAMPT
SCHEMBL21167396 0.89 MET (0.39) CSF1RMETKEAP1NQO2NAMPT
SCHEMBL21167421 0.87 CSF1R (0.59) CSF1RMETKEAP1NQO2LDHA
SCHEMBL22475658 0.86 CSF1R (0.46) CSF1RMETKEAP1NQO2LDHA
SCHEMBL22475857 0.85 MET (0.38) METKEAP1NQO2NAMPTPAK1
SCHEMBL21167480 0.84 MET (0.47) CSF1RMETKEAP1NQO2NAMPT
SCHEMBL21167380 0.83 DYRK1A (0.44) CSF1RMETKEAP1NAMPTFGFR2
SCHEMBL21167404 0.82 MET (0.58) CSF1RMETKEAP1LDHALDHB
SCHEMBL24590985 0.82 MET (0.46) CSF1RMETTYRO3
SCHEMBL24590986 0.81 MET (0.59) CSF1RMETKEAP1NAMPTLDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3795573-A1 CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRIDINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR Hutchison Medipharma Limited (CN) 2021-03-24 EP disclosed
EP-3511330-B1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS HUTCHISON MEDIPHARMA LTD (CN) 2020-09-30 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed